Dabur India Shares Edge Lower In Early Trade After USFDA Action 

Mumbai, June 2: FMCG major Dabur India shares on Tuesday were trading in the negative territory in early trade after the US food regulator issued an observation on its facility located in Silvassa, Dadra and Nagar Haveli.

The United States Food & Drug Administration (USFDA) last week issued a red flag, pointing to serious manufacturing, maintenance and data integrity lapses at a Dabur India plant.
The regulator has identified multiple deficiencies at the plant in Silvasa, raising concerns over potential microbiological contamination and compliance with manufacturing standards.

Following this, the share of Dabur India tumbled by Rs 18.95 on Monday. It had closed at Rs 443.60 on Friday.

Stock Market Snapshot on June 2, 2026

Dabur India shares traded in negative territory during early trading on June 2, 2026, reflecting mild selling pressure amid broader market activity.

As of 9:46 AM IST, the stock was trading at ₹423.25, down 0.32% from the previous close of ₹424.60. The stock opened at ₹421.55 and moved between ₹425.60 and ₹420.30.

Despite the decline, the movement remained within a narrow trading range, suggesting a largely range-bound session so far. Dabur India commanded a market of approximately ₹75,070 crore, while the stock traded at a P/E ratio of 39.59.

Investors will continue to monitor sector trends, consumer demand indicators and company-specific developments for further cues during the session.

Dabur Clarification

Dabur issued a statement clarifying that “the observations provided by concerns only a small part of our manufacturing plant situated at Silvassa, Dadra and Nagar Haveli, which generates insignificant revenue for the company”.

This plant continues to be operational.

“We are actively engaged with the USFDA on the findings of the audit and have built a robust corrective and preventive action plan to resolve the concerns raised, which has been shared with the USFDA with updates on the progress being shared regularly,” Dabur India said.

It further said Dabur will continue to implement strong controls to ensure that its quality systems are never compromised.

“We are committed to maintaining the highest standards of product quality in our manufacturing operations at all our sites and ensuring optimal consumer experience,” it said.

Moreover, Dabur also assured that its products are manufactured and delivered with the highest level of quality and hygiene, which is in strict compliance with applicable regulations, standards and specifications.

“As of now, there is no impact on financial, operations or other activities of the company due to the above,” said Dabur India.

(with inputs fro PTI)